Acute Asthma Exacerbation — Management Pathway
Grade severity by GINA (speech / breathing / SpO2 / PEF / consciousness) to guide SABA, steroids, magnesium and ventilatory escalation.
Severe: Frequent/continuous nebulized SABA + ipratropium (SAMA); controlled oxygen SpO2 93–95%; early systemic steroid (prednisolone 40–50 mg orall…
Step-by-step decision
Choose step by step as prompted; reaching an endpoint gives the management recommendation. You can go back a step or restart anytime.
🎓 Want to practice? Do a case challenge with this pathway → (get a case, choose management step by step, scored).
Full pathway
- [Decision] Severity assessmentHow severe is the exacerbation? (GINA: speaks in full sentences / prefers sitting / not agitated / SpO2 90–95% / PEF >50% = mild–moderate; speaks in words only / sits hunched / agitated / RR >30 / accessory muscle use / HR >120 / SpO2 <90% / PEF ≤50% = severe; drowsy, confused, silent chest, bradycardia = life-threatening.)
- Mild–moderate → Mild–moderate
- Severe → Severe
- Life-threatening → Life-threatening
- [End] Mild–moderateRepeated inhaled SABA (salbutamol, MDI with spacer or nebulizer); controlled oxygen targeting SpO2 93–95%; oral systemic steroid (prednisolone 40–50 mg); reassess PEF/symptoms at 1 h. If improved, continue and make a discharge control plan; if not, escalate as severe. Do not routinely order chest X-ray or blood gas.
- [End] SevereFrequent/continuous nebulized SABA + ipratropium (SAMA); controlled oxygen SpO2 93–95%; early systemic steroid (prednisolone 40–50 mg orally, or IV hydrocortisone/methylprednisolone); add magnesium sulfate 2 g IV (over 20 min) if poor response. Close monitoring in ED/inpatient, reassess at 1 h, escalate if worsening.
- [End] Life-threateningLife-threatening (silent chest / altered consciousness / signs of respiratory failure): ICU; continuous nebulized SABA + ipratropium, IV steroid, magnesium sulfate; non-invasive ventilation or early intubation (use an obstructive-lung ventilation strategy — low rate, long expiration, permissive hypercapnia). (Note: Marked respiratory distress without wheeze suggests impending respiratory failure. Differentiate anaphylaxis, pneumonia, PE, heart failure.)
Source guidelines & references
- GINA 2025 Global Strategy for Asthma Management and Prevention · source ↗
This pathway is our own synthesis of the decision logic in the guidelines above (not the guideline verbatim); thresholds and workflows change as guidelines update — in practice follow the latest guideline, your institution's protocol and the individual patient.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.